Loading...
Gilead Sciences, Inc.
GIS.DE•XETRA
HealthcareDrug Manufacturers - General
€97.90
€-0.06(-0.06%)
Gilead Sciences, Inc. (GIS.DE) Financial Performance & Statements
Review Gilead Sciences, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
6.04%
↑ 6.04%
Operating Income Growth
-78.15%
↓ 78.15%
Net Income Growth
-91.53%
↓ 91.53%
Operating Cash Flow Growth
35.25%
↑ 35.25%
Operating Margin
27.12%
↑ 27.12%
Gross Margin
78.71%
↑ 78.71%
Net Profit Margin
21.07%
↑ 21.07%
ROE
25.26%
↑ 25.26%
ROIC
12.73%
↑ 12.73%
Gilead Sciences, Inc. (GIS.DE) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Gilead Sciences, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $7.57B | $7.54B | $6.95B | $6.69B |
| Cost of Revenue | $1.58B | $1.57B | $1.54B | $1.55B |
| Gross Profit | $5.99B | $5.97B | $5.41B | $5.13B |
| Gross Profit Ratio | $0.79 | $0.79 | $0.78 | $0.77 |
| R&D Expenses | $1.64B | $1.40B | $1.35B | $1.47B |
| SG&A Expenses | $1.91B | $1.43B | $1.37B | $1.36B |
| Operating Expenses | $3.55B | $5.08B | $2.72B | $2.83B |
| Total Costs & Expenses | $5.12B | $6.66B | $4.26B | $4.38B |
| Interest Income | $85.00M | $52.00M | $0.00 | $0.00 |
| Interest Expense | $248.00M | $237.00M | $237.00M | $254.00M |
| Depreciation & Amortization | $693.00M | $690.00M | $694.00M | $690.00M |
| EBITDA | $3.11B | $1.88B | $2.98B | -$3.54B |
| EBITDA Ratio | $0.41 | $0.25 | $0.43 | -$0.53 |
| Operating Income | $2.45B | $888.00M | $2.69B | $2.30B |
| Operating Income Ratio | $0.32 | $0.12 | $0.39 | $0.34 |
| Other Income/Expenses (Net) | -$283.00M | $68.00M | -$635.00M | -$6.79B |
| Income Before Tax | $2.17B | $956.00M | $2.05B | -$4.49B |
| Income Before Tax Ratio | $0.29 | $0.13 | $0.30 | -$0.67 |
| Income Tax Expense | $385.00M | -$297.00M | $438.00M | -$315.00M |
| Net Income | $1.78B | $1.25B | $1.61B | -$4.17B |
| Net Income Ratio | $0.24 | $0.17 | $0.23 | -$0.62 |
| EPS | $1.43 | $1.00 | $1.29 | -$3.34 |
| Diluted EPS | $1.42 | $1.00 | $1.29 | -$3.34 |
| Weighted Avg Shares Outstanding | $1.25B | $1.25B | $1.25B | $1.25B |
| Weighted Avg Shares Outstanding (Diluted) | $1.26B | $1.25B | $1.25B | $1.25B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan